CIPO Patents = 1

Forward Citations = 2

Loading Chart...

2 inventors (with patents filed for the assignee):

David R Tabatadze (5 out of 9 patents)

Ivan Yanachkov (3 out of 5 patents)

5 patents: Sort by Forward Citations

1. 12297225 - Detection method for natural and modified small nucleic acids (2025-05-13),

2. 11566042 - Phosphoramidite synthones for the synthesis of self-neutralizing oligonucleotide compounds (2023-01-31),

3. 10738005 - Aziridinyl containing compounds and methods of inactivating nucleic acid molecules using the same (2020-08-11),

4. 10723755 - Phosphoramidite synthones for the synthesis of self-neutralizing oligonucleotide compounds (2020-07-28),

5. 10173976 - Aziridinyl containing compounds and methods of inactivating nucleic acid molecules using the same (2019-01-08),

Zata Pharmaceuticals, Inc. is a leading biopharmaceutical company dedicated to developing innovative therapies for various diseases. With a focus on research and development, Zata Pharmaceuticals strives to improve patient outcomes and quality of life. Our team of experts is committed to delivering high-quality, safe, and effective medications to meet the needs of patients worldwide.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 16 2025

5 Patents

#41 in Worcester, MA

#2,815 in Massachusetts

#50,174 in US

Worcester, MA, United States of America

Zata Pharmaceuticals, Inc.

Forward Citations = 2

2 inventors:

David R Tabatadze (5 out of 9 patents)

Ivan Yanachkov (3 out of 5 patents)

Please report any incorrect information to support@idiyas.com

1 patent (CIPO):

Please report any incorrect information to support@idiyas.com